UCSF Carol Franc Buck Breast Care Center

What UCSF Carol Franc Buck Breast Care Center does

The UCSF Carol Franc Buck Breast Care Center is a specialized clinical and research facility operating within the UCSF Helen Diller Family Comprehensive Cancer Center, itself part of the public University of California San Francisco academic medical system. The center provides multidisciplinary breast care across the full continuum from prevention and screening through diagnosis, treatment, surgery, chemotherapy, radiation therapy, immunotherapy, and survivorship support. Its patient base comprises breast cancer patients, women at elevated risk due to family history or fibrocystic conditions, and individuals seeking general breast health consultations across Northern California and the San Francisco Bay Area, with international referral flow.

The center's underlying technology stack includes pioneering adaptive clinical trial designs that incorporate repeated MR imaging and tissue analyses during treatment, a 7 Tesla superconducting MRI laboratory capable of imaging blood vessels 100-200 microns in diameter, and developed technologies including immunoliposomes for targeted chemotherapy and Comparative Genomic Hybridization. The center leads the ATHENA Breast Health Network across all five UC medical centers (over 150,000 women) and the national WISDOM Study for personalized screening. Over 250 active clinical trials are available through UCSF at any given time, with 14% of adult and 54% of pediatric cancer patients enrolled in trials. Faculty have included Nobel laureates J. Michael Bishop (1989) and Elizabeth Blackburn (2009).

The center does not operate as a standalone revenue entity. As a department within the public University of California system, revenue derives from clinical care billed through UCSF Health systems and standard insurance reimbursement, supplemented by federal research funding (over $64M from NCI in 2022 to the broader cancer center, part of $823M total NIH funding to UCSF) and public-private research partnerships with Novartis, Genentech, Pfizer, Sanofi, Parker Institute for Cancer Immunotherapy, Stand Up to Cancer, and Lawrence Berkeley National Laboratory. Patient access is via physician referral or direct appointment through the UCSF Health website.

Name

UCSF Carol Franc Buck Breast Care Center

Legal name

UCSF Carol Franc Buck Breast Care Center

Website

https://ucsfbreastcarecenter.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The UCSF Carol Franc Buck Breast Care Center is a specialized clinical and research facility within the UCSF Helen Diller Family Comprehensive Cancer Center that provides multidisciplinary breast cancer care from prevention through survivorship, while leading national clinical trials and large-scale breast health screening research for patients across Northern California.

Ownership category

akta.pro rank

Product category

Breast Cancer Treatment and Care

NAICS

Diagnostic Imaging Centers (621512), General Medical and Surgical Hospitals (62211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Breast Oncology (HLAKAFAJ)

akta.pro secondary industries

Women’s Imaging & Breast Health Centers (HLAFAJAJ), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Breast cancer treatment
• Breast health screening
• Oncology clinical care
• Cancer clinical trials
• Survivorship support services

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Patient Care Services: Revenue generated from clinical care services including diagnostic procedures, treatment services, surgical procedures, and follow-up care for breast cancer patients. Services are billed through standard medical insurance and UCSF Health billing systems.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

The UCSF Carol Franc Buck Breast Care Center provides specialized, multidisciplinary breast health services spanning prevention and screening for high-risk women, diagnosis, treatment (including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy), clinical trials, and survivorship support. The center integrates direct patient care with translational research through the UCSF Helen Diller Family Comprehensive Cancer Center and accepts patients referred by physicians or self-referred.

Product overview

The UCSF Breast Care Center (Carol Franc Buck Breast Care Center) is a specialized healthcare facility within the UCSF Helen Diller Family Comprehensive Cancer Center. It provides a comprehensive, multidisciplinary approach to breast health, offering services across the care continuum including prevention and screening, diagnosis, treatment, and survivorship support. The center integrates clinical care with research and clinical trials to advance breast cancer treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• UCSF Carol Franc Buck Breast Care Center — Clinical Care Services Specialized, multidisciplinary breast care from prevention and screening through diagnosis, treatment (surgery, chemotherapy, radiation, immunotherapy, targeted therapy), and survivorship support for individual patients with breast problems or breast cancer.
• Treatment and Survivorship Program Information and care services covering diagnosis, surgical options, treatment choices, decision support, and survivorship resources for breast cancer patients.
• Prevention and Screening Program Prevention and screening services tailored for women at increased risk of breast cancer due to family history, previous cancer diagnosis, or fibrocystic breasts, including risk assessment and enhanced screening.
• Breast Cancer Clinical Trials Active breast cancer clinical trials covering prevention, diagnosis, treatment, and quality-of-life improvement, conducted by UCSF clinicians as part of the broader 250+ clinical trial portfolio at the cancer center.
• Support Services and Educational Resources Patient support services and educational resources promoting health and wellness across the breast cancer care journey, including Art for Recovery, Cancer Support Center, Psycho-Oncology, Social Work, Survivorship, and Symptom Management programs.

Quantifiable outcome

• Top 4% of nation's cancer centers - NCI-designated Comprehensive Cancer Center
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core, flagship and minor.

• Lawrence Berkeley National LaboratorycoreStrategic or Co-development PartnerUCSF collaborates closely with Lawrence Berkeley National Laboratory to leverage unique strengths at both institutions in cancer research and technological discovery. Collaborative opportunities extend to joint proposals for extramural funding and leadership positions at the Cancer Center by LBNL investigators. Scientific areas include cancer biology (immunology, systems biology, radiobiology, DNA repair, stem cell biology, molecular oncology), therapy development, computational biology, multi-scale imaging, genomics, and nanotechnology.
• Stand Up to Cancer (SU2C)flagshipStrategic or Co-development PartnerUCSF leads or participates in four SU2C Dream Teams for prostate, breast, pancreas, and lung cancer. Teams include Pancreas ($8M), Lung ($20M), Prostate ($10M), and Breast ($17.5M) cancer research initiatives focused on developing novel treatments and therapeutic approaches.
• ATHENA Breast Health NetworkflagshipStrategic or Co-development PartnerCollaborates in ATHENA Breast Health Network, a groundbreaking project to improve survival and reduce suffering from breast cancer. Network includes all five University of California medical centers and serves more than 150,000 women.
• WISDOM StudyflagshipStrategic or Co-development PartnerLeads the national WISDOM Study to evaluate a personalized approach to breast cancer screening and risk assessment. Part of ATHENA Breast Health Network initiative.
• Children's Oncology Group (COG)coreStrategic or Co-development PartnerMember of COG Phase 1 Consortium, an elite NCI consortium selected to lead studies of potential pediatric cancer drugs. UCSF is one of only two COG Phase 1 institutions in California, and one of only 21 centers in the US and Canada.
• NovartisminorStrategic or Co-development PartnerStrategic partnership for cancer research funding and drug development collaboration as part of public-private partnerships to advance biomedical research.
• GenentechminorStrategic or Co-development PartnerStrategic partnership for cancer research collaboration and potential drug development initiatives.
• Parker Institute for Cancer ImmunotherapycoreStrategic or Co-development PartnerStrategic partnership focused on advancing cancer immunotherapy research and clinical translation.
• PfizerminorStrategic or Co-development PartnerPublic-private partnership for cancer research funding and collaboration.
• SanofiminorStrategic or Co-development PartnerPublic-private partnership for cancer research funding and collaboration.
• Association of American Cancer InstitutescoreStrategic or Co-development PartnerUCSF is a member of the Association of American Cancer Institutes, a group of leading US research centers with comprehensive multidisciplinary programs of cancer research, treatment, patient care, prevention, education and community outreach.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mayo Clinic Cancer Center: NCI Comprehensive Cancer Center operating across multiple sites with a dedicated breast cancer clinic, comparable to UCSF in multidisciplinary structure, NCI designation, and integrated research-clinical model.
• Dana-Farber Cancer Institute: Harvard-affiliated NCI Comprehensive Cancer Center with a high-volume breast oncology program and heavy emphasis on clinical trials and precision medicine — directly comparable to UCSF in research intensity and academic affiliation.
• MD Anderson Cancer Center: Leading NCI Comprehensive Cancer Center with one of the largest breast cancer programs globally. Comparable to UCSF in NCI designation, NIH funding scale, clinical trial volume, and reputation as a global research powerhouse.
• UCLA Jonsson Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center within the same University of California system. ATHENA network partner and direct peer in breast cancer research, NCI funding competition, and clinical trial enrollment.
• Johns Hopkins Sidney Kimmel Cancer Center: NCI-designated Comprehensive Cancer Center with a dedicated breast cancer program and deep research portfolio, comparable to UCSF in academic intensity, NCI designation, and clinical trial leadership.
• University of Chicago Medicine Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with a dedicated breast cancer program operating within an academic medical center structure analogous to UCSF's, including comparable multidisciplinary clinical trials infrastructure.
• Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center with deep expertise in breast oncology, immunotherapy, and clinical trials — directly comparable to UCSF in research intensity and translational science.
• Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center with a flagship breast cancer program offering multidisciplinary diagnosis, treatment, and clinical trials. Most directly comparable to UCSF's Breast Care Center in scale, NCI designation, NCCN membership, and research intensity.

Regional players

• Cedars-Sinai Samuel Oschin Cancer Center: Major regional cancer program with a breast cancer service line competing for Los Angeles / Southern California patient share. Less research-intensive than UCSF but a notable competitor in the broader California breast oncology market.
• Stanford Cancer Institute: NCI-designated cancer center at Stanford with a breast cancer program serving the same Northern California market. Operates in the same Bay Area catchment and competes directly for patients, referrals, and trial sponsorship.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@UCSFCancer
• LinkedInlinkedin.com/company/ucsf-carol-franc-buck-breast-care-center

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UCSF Carol Franc Buck Breast Care Center